2022
DOI: 10.3389/fmed.2022.1043840
|View full text |Cite
|
Sign up to set email alerts
|

Current advances in the selection of adjuvant radiotherapy regimens for keloid

Abstract: Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is mostly used in clinical treatment. Adjuvant radiotherapy is currently one of the most effective treatments for keloid. After long-term clinical practice, brachytherapy and electron beam radiotherapy has increasingly bec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 126 publications
0
1
0
Order By: Relevance
“…Both regimens showed excellent responses with minimum recurrence rates; however, the second regimen was aesthetically superior to the treatment [469]. Compared with TAC injection alone, the combination of pulsed dye laser and TAC shortened the relative cure time, reduced the number of TAC injections, and improved the clinical efficacy in the treatment of KD with post-operative recurrence [470].…”
Section: Pharmacotherapy Combined With Surgical Excision and Laser Th...mentioning
confidence: 99%
“…Both regimens showed excellent responses with minimum recurrence rates; however, the second regimen was aesthetically superior to the treatment [469]. Compared with TAC injection alone, the combination of pulsed dye laser and TAC shortened the relative cure time, reduced the number of TAC injections, and improved the clinical efficacy in the treatment of KD with post-operative recurrence [470].…”
Section: Pharmacotherapy Combined With Surgical Excision and Laser Th...mentioning
confidence: 99%